Rectum -- Cancer

Llistar Títols per Matèria "Rectum -- Cancer"

S'han trobat 24 ítems

Llistant ítems des de 0 a 24:

  1   
FormatDataTítolAutor
FormatDataTítolAutor
doc icon DUGiDocs gener 2016 Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer López Siles, Mireia ; Martínez Medina, Margarita ; Surís Valls, Romà ; Aldeguer i Manté, Xavier ; Sàbat Mir, Míriam ; Duncan, Sylvia H. ; Flint, Harry J. ; Garcia-Gil, L. J.
doc icon DUGiDocs juny 2018 Desmetilació genòmica com a biomarcador de predisposició a càncers múltiples Navarro Jiménez, Maria
out url icon Recercat Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients Cubiella, Joaquín ; Vega, Pablo ; Salve, María ; Díaz Ondina, Marta ; Alves, Maria Teresa ; Quintero, Enrique ; Álvarez Sánchez, Victoria ; Fernández Bañares, Fernándo ; Boadas, Jaume ; Campo, Rafel ; Bujanda, Luis ; Clofent, Joan ; Ferrandez, Ángel ; Torrealba, Leyanira ; Piñol Sánchez, Virgínia ; Rodríguez Alcalde, Daniel ; Hernández, Vicent ; Fernández Seara, Javier
out url icon Recercat Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients Cubiella, Joaquín ; Vega, Pablo ; Salve, María ; Díaz Ondina, Marta ; Alves, Maria Teresa ; Quintero, Enrique ; Álvarez Sánchez, Victoria ; Fernández Bañares, Fernándo ; Boadas, Jaume ; Campo, Rafel ; Bujanda, Luis ; Clofent, Joan ; Ferrandez, Ángel ; Torrealba, Leyanira ; Piñol Sánchez, Virgínia ; Rodríguez Alcalde, Daniel ; Hernández, Vicent ; Fernández Seara, Javier
out url icon Recercat 1 juny 2018 Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients
out url icon Recercat 5 juny 2018 Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients Cubiella, Joaquín ; Vega, Pablo ; Salve, María ; Díaz Ondina, Marta ; Alves, Maria Teresa ; Quintero, Enrique ; Álvarez Sánchez, Victoria ; Fernández Bañares, Fernándo ; Boadas, Jaume ; Campo, Rafel ; Bujanda, Luis ; Clofent, Joan ; Ferrandez, Ángel ; Torrealba, Leyanira ; Piñol Sánchez, Virgínia ; Rodríguez Alcalde, Daniel ; Hernández, Vicent ; Fernández Seara, Javier
doc icon DUGiDocs 31 agost 2016 Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients Cubiella, Joaquín ; Vega, Pablo ; Salve, María ; Díaz Ondina, Marta ; Alves, Maria Teresa ; Quintero, Enrique ; Álvarez Sánchez, Victoria ; Fernández Bañares, Fernándo ; Boadas, Jaume ; Campo, Rafel ; Bujanda, Luis ; Clofent, Juan ; Ferrandez, Ángel ; Torrealba, Leyanira ; Piñol Sánchez, Virgínia ; Rodríguez Alcalde, Daniel ; Hernández, Vicent ; Fernández Seara, Javier
doc icon DUGiDocs 2018 La dieta com a prevenció primària pel desenvolupament del càncer colorectal: revisió bibliogràfica Soler Renart, Anna
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
out url icon Recercat 1 juny 2018 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models
out url icon Recercat 5 juny 2018 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz, Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2011 Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models Oliveras Ferrarós, Cristina ; Vázquez Martín, Alejandro ; Queralt, Bernardo ; Adrados, Manuel ; Ortiz Duran, Maria Rosa ; Cufí González, Sílvia ; Hernández Yagüe, Xavier ; Guardeño, Raquel ; Báez, Luciana ; Martin Castillo, Begoña ; Pérez Martínez, Maria Carmen ; López Bonet, Eugeni ; Llorens Duran, Rafael de ; Bernadó, Luis ; Brunet i Vidal, Joan ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 8 febrer 2016 Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposis Mur, Pilar ; Sánchez Cuartielles, Elena ; Aussó, Susanna ; Aiza, Gemma ; Valdés Mas, Rafael ; Pineda, Marta ; Navarro, Matilde ; Brunet i Vidal, Joan ; Urioste, Miguel ; Lázaro, Conxi ; Moreno, Victor ; Capellá, Gabriel ; Puente, Xose S. ; Valle, Laura
doc icon DUGiDocs 12 setembre 2016 Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
out url icon Recercat Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
out url icon Recercat Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
out url icon Recercat 1 juny 2018 Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer
out url icon Recercat 5 juny 2018 Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer Queralt, Bernardo ; Cuyàs, Elisabet ; Bosch Barrera, Joaquim ; Massaguer i Vall-llovera, Anna ; Llorens Duran, Rafael de ; Martin Castillo, Begoña ; Brunet i Vidal, Joan ; Salazar, Ramon ; Menéndez Menéndez, Javier Abel
doc icon DUGiDocs 2012 Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrarós, Cristina ; Massaguer i Vall-llovera, Anna ; Vázquez Martín, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cufí González, Sílvia ; Martin Castillo, Begoña ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Menéndez Menéndez, Javier Abel
out url icon Recercat Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrarós, Cristina ; Massaguer i Vall-llovera, Anna ; Vázquez Martín, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cufí González, Sílvia ; Martin Castillo, Begoña ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Menéndez Menéndez, Javier Abel
out url icon Recercat Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrarós, Cristina ; Massaguer i Vall-llovera, Anna ; Vázquez Martín, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cufí González, Sílvia ; Martin Castillo, Begoña ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Menéndez Menéndez, Javier Abel
out url icon Recercat 1 juny 2018 Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment
out url icon Recercat 5 juny 2018 Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment Oliveras Ferrarós, Cristina ; Massaguer i Vall-llovera, Anna ; Vázquez Martín, Alejandro ; Carrion Salip, Dolors ; Queralt, Bernardo ; Cufí González, Sílvia ; Martin Castillo, Begoña ; Bosch Barrera, Joaquim ; Brunet i Vidal, Joan ; Llorens Duran, Rafael de ; Menéndez Menéndez, Javier Abel
  1   

Matèries

Autors